Platelet function in autoimmune (idiopathic) thrombocytopenic purpura

Platelets play an essential role in the formation of haemostatic plugs. The quantitative defect of platelets in autoimmune (idiopathic) thrombocytopenic purpura (ITP) can result in bleeding complications, but most ITP patients have platelets with normal or enhanced function. Platelets in ITP are large, young, so‐called “stress” platelets with increased platelet‐associated autoimmune antibody (immunoglobulin G). Young stress platelets are more functional platelets, and their presence may account for bleeding times in ITP patients that are shorter than would be predicted on the basis of the patients' (low) platelet counts. Some ITP patients have significant mucocutaneous bleeding with platelet counts >50 × 109 l−1; this may be due to qualitative platelet dysfunction (e.g. brought about by inhibitory antiplatelet autoantibodies).

[1]  R. Silver,et al.  Congenital disorders of platelet function. , 1999, Clinical obstetrics and gynecology.

[2]  S. Hauser.  Autoimmune (idiopathic) thrombocytopenic purpura , 1997, The Lancet.

[3]  J. Sixma,et al.  Platelet Adhesion to Collagen: an Update , 1997, Thrombosis and Haemostasis.

[4]  K. Siminovitch,et al.  Flow cytometric analysis of platelets from childrenwith the Wiskott‐Aldrich syndrome reveals defects in platelet development, activation and structure , 1997, British journal of haematology.

[5]  S. Kundu,et al.  Characterization of an In Vitro Platelet Function Analyzer, PFA-100™ , 1996 .

[6]  S. Watson,et al.  Platelets: A Practical Approach , 1996 .

[7]  H. Yamamura,et al.  Cyclic AMP-insensitive Activation of c-Src and Syk Protein-tyrosine Kinases through Platelet Membrane Glycoprotein VI (*) , 1995, The Journal of Biological Chemistry.

[8]  M. Packham.  Role of platelets in thrombosis and hemostasis. , 1994, Canadian journal of physiology and pharmacology.

[9]  T. Kawakatsu,et al.  Platelet activation induced by an antiplatelet autoantibody against CD9 antigen and its inhibition by another autoantibody in immune thrombocytopenic purpura , 1993, British journal of haematology.

[10]  J. Bennett.  Mechanisms of platelet adhesion and aggregation: an update. , 1992, Hospital practice.

[11]  L. Horstman,et al.  Clinical significance of platelet microparticles in autoimmune thrombocytopenias. , 1992, The Journal of laboratory and clinical medicine.

[12]  J. Slupsky,et al.  Platelet activation by immobilized monoclonal antibody: evidence for a CD9 proximal signal. , 1991, Blood.

[13]  S. Nomura,et al.  Influences of antiplatelet autoantibodies on platelet function in immune thrombocytopenic purpura , 1991, European journal of haematology.

[14]  L. Jennings,et al.  The activation of human platelets mediated by anti-human platelet p24/CD9 monoclonal antibodies. , 1990, The Journal of biological chemistry.

[15]  M. Kroll,et al.  Biochemical mechanisms of platelet activation. , 1989, Blood.

[16]  P. Sims,et al.  Complement proteins C5b-9 cause release of membrane vesicles from the platelet surface that are enriched in the membrane receptor for coagulation factor Va and express prothrombinase activity. , 1988, The Journal of biological chemistry.

[17]  F. Ushikubi,et al.  A novel platelet aggregating factor found in a patient with defective collagen-induced platelet aggregation and autoimmune thrombocytopenia. , 1987, Blood.

[18]  D. Fugman,et al.  Platelet membrane vesicles reduced microvascular bleeding times in thrombocytopenic rabbits. , 1987, The Journal of laboratory and clinical medicine.

[19]  C. Thompson,et al.  Platelet size as a determinant of platelet function. , 1983, The Journal of laboratory and clinical medicine.

[20]  C. Thompson,et al.  Arachidonic acid metabolism by platelets of differing size , 1983, British journal of haematology.

[21]  C. Thompson,et al.  Size dependent platelet subpopulations: relationship of platelet volume to ultrastructure, enzymatic activity, and function , 1982, British journal of haematology.

[22]  J. George,et al.  Hemostatic function, survival, and membrane glycoprotein changes in young versus old rabbit platelets. , 1981, The Journal of clinical investigation.

[23]  J. Kelton,et al.  Abnormal platelet function and arachidonate metabolism in chronic idiopathic thrombocytopenic purpura. , 1981, Blood.

[24]  H. Weiss,et al.  Acquired storage pool deficiency with increased platelet-associated IgG. Report of five cases. , 1980, The American journal of medicine.

[25]  S. Karpatkin.  Autoimmune thrombocytopenic purpura. , 1980, The American journal of the medical sciences.

[26]  V. Marder,et al.  Acquired "storage pool disease" of platelets associated with circulating antiplatelet antibodies. , 1974, The American journal of medicine.

[27]  R. Aster,et al.  Changes Associated with Platelet Aging , 1972, Thrombosis and Haemostasis.

[28]  L. Harker,et al.  The bleeding time as a screening test for evaluation of platelet function. , 1972, The New England journal of medicine.

[29]  R. Clancy,et al.  Qualitative platelet abnormalities in idiopathic thrombocytopenic purpura. , 1972, The New England journal of medicine.

[30]  J. Hirsh,et al.  The effect of platelet age on platelet adherence to collagen. , 1968, The Journal of clinical investigation.

[31]  A. Sharp.  The Assessment of Platelet Function , 1959, Postgraduate medical journal.

[32]  J. George,et al.  Aged platelets have an impaired response to thrombin as quantitated by P-selectin expression. , 1994, Blood.

[33]  K. Clemetson,et al.  Autoantibodies against the platelet glycoproteins (GP) IIb/IIIa, Ia/IIa, and IV and partial deficiency in GPIV in a patient with a bleeding disorder and a defective platelet collagen interaction. , 1993, Blood.

[34]  Platelets: receptors, adhesion, secretion. Part A. , 1989, Methods in enzymology.

[35]  J. Hawiger.  Platelets : receptors, adhesion, secretion , 1989 .

[36]  P. D. de Groot,et al.  Interaction of blood platelets with the vessel wall. , 1988, Haemostasis.